Patrick Ta Beauty sues CVS for selling product without authorization — the unauthorized retail placement problem

Patrick Ta Beauty filed suit against CVS and Canadian distributor Akstrom for selling its cosmetics in CVS stores without the brand's approval, according to Glossy. The products appeared in CVS' newly-launched format without a direct supply agreement between the brand and the retailer.

The mechanism: a third-party distributor sourced Patrick Ta products — likely through gray-market channels or secondary buyers — and placed them with CVS under the distributor's own terms. CVS stocked the inventory without confirming authorized distribution. The brand discovered its products on CVS shelves in a retail environment it had not approved and at price points it did not control. Patrick Ta Beauty's lawsuit names both CVS and Akstrom, asserting that unauthorized placement damages brand positioning and dilutes the prestige channel strategy the company built through Sephora and its own DTC operation.

This works because retail buyers, especially at volume chains launching new beauty formats, prioritize inventory fill rate and recognizable SKUs over distributor verification. A buyer sees a known brand, a distributor offers competitive terms, and the product goes to shelf. The brand learns about placement only when a customer tags the retailer on social or when the company's field team spots the product during a store audit. For prestige brands that control distribution to maintain price integrity and retail environment quality, unauthorized placement introduces price erosion, channel conflict with authorized partners, and consumer confusion about where the brand belongs.

The broader pattern: as mass retailers expand into prestige beauty — CVS, Walgreens, Target all testing new formats — gray-market distributors exploit the gap between retailer demand for marquee brands and those brands' selective distribution policies. Distributors acquire product through parallel import, overstock buys, or secondary wholesale markets, then pitch retailers as if they hold authorized distribution rights. Retailers often do not require proof of brand authorization before purchase, especially when the distributor underwrites inventory risk and offers favorable payment terms.

The steal for a small physical-product brand: this is a defensive play, not an offensive one. If you sell through selective retail or maintain different pricing across DTC and wholesale, unauthorized placement will eventually surface. Here is the sequence to prevent it or respond early.

First, write explicit authorized reseller language into every wholesale agreement. State that the buyer may not resell to any retailer, distributor, or marketplace without your written approval. Include a retailer whitelist if you have one. This clause gives you contractual standing if product leaks into unauthorized channels. Second, monitor major retail chains monthly. Assign one person to walk the aisles of Target, CVS, Walgreens, TJ Maxx, Marshalls, and regional chains in your category. Photograph any appearance of your product. Track price, placement, and signage. If you cannot visit in person, hire a regional field service to audit 10-15 stores per month for under $500. Third, when you find unauthorized placement, send a cease-and-desist letter the same week to both the retailer's buyer and the distributor on the invoice, if you can identify them. Demand removal and disclosure of the supply chain. Most retailers will pull product quietly to avoid litigation. Fourth, if the retailer does not respond or if placement continues, file for preliminary injunction in federal court to stop sales while you litigate. This is the move Patrick Ta took. The cost to file runs $5,000-$10,000 in legal fees for initial motions, but it signals to the market that you enforce distribution policy, which deters other distributors from attempting the same route.

For brands with limited legal budget, the alternative is to preemptively license or supply the retailer yourself on your terms. If CVS or a similar chain is testing your category, approach the buyer directly with a pilot offer before a distributor does. You control price, placement, and contract terms, and you eliminate the gray-market window.

The Patrick Ta case puts every prestige and emerging brand on notice: unauthorized retail placement is no longer rare opportunism. It is a structured arbitrage play by distributors who know that most brands will not litigate and most retailers will not verify supply chain provenance until a lawsuit lands. If you sell physical product and you care where it appears, enforcement is now a line item in your operating budget.